MedPath

Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals

Phase 2
Completed
Conditions
Lipidemia
Healthy
Registration Number
NCT03741621
Lead Sponsor
Unity Health Toronto
Brief Summary

To investigate the role of fibre viscosity (low, medium, high) in lowering cholesterol in healthy individuals

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria

-healthy individuals

Exclusion Criteria
  • regular alcohol consumption
  • regular smoking

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
change in LDL cholesterolchange from baseline after 21 days, relative to control
Secondary Outcome Measures
NameTimeMethod
change in apolipoprotein A-1change from baseline after 21 days, relative to control
change in HDL cholesterolchange from baseline after 21 days, relative to control
change in total cholesterolchange from baseline after 21 days, relative to control
change in apolipoprotein Bchange from baseline after 21 days, relative to control
change in triglycerideschange from baseline after 21 days, relative to control

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.